Classification criteria for neuropsychiatric systemic lupus erythematosus: do they need a discussion?
- PMID: 18923663
- PMCID: PMC2464312
Classification criteria for neuropsychiatric systemic lupus erythematosus: do they need a discussion?
Abstract
Background: At the current stage, the criteria for making the diagnosis of SLE (ARA, 1982) include only two neuropsychiatric manifestations: seizures and psychoses. In view of the need for early detection of the lesions of the nervous system, we set ourselves to the task of developing an approach for making the diagnosis of NPSLE (neuropsychiatric SLE) on the basis of criteria with high sensitivity and specificity.
Methods: In view of determining the type and incidence of the lesions of the nervous system (NS), clinical, laboratory, and instrumental examinations were performed within the period from 1998 to 2006 in 225 patients with SLE. Depending on the specific features of the clinical course, these patients were divided into three groups: with clinically manifested lesions of NS; without clinically manifested lesions of NS; and with incomplete SLE.
Results and conclusions: The results from the performed examinations showed a high percentage (64.44%) of neuropsychiatric lesions in the patients with SLE. According our results, NPSLE diagnosis should be made in the presence of at least one indicator from the first group of criteria (seizures, psychosis, cerebrovascular event, lesion of cranial nerves, motor disturbances, quantitative alterations of consciousness) and at least two indicators from the second group of criteria (cognitive dysfunction, headache due to lupus, peripheral neuropathy, MRI changes, EEG changes, ENMG changes, positive aRPA, positive aPL) after ruling out other causes (except for SLE) for their occurrence.
Keywords: classification criteria; neuropsychiatric systemic lupus erythematosus.
Similar articles
-
Psychosis in patients with systemic lupus erythematosus.Indian J Psychol Med. 2012 Jan;34(1):90-3. doi: 10.4103/0253-7176.96170. Indian J Psychol Med. 2012. PMID: 22661818 Free PMC article.
-
Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort.Semin Arthritis Rheum. 2012 Oct;42(2):179-85. doi: 10.1016/j.semarthrit.2012.03.011. Epub 2012 May 16. Semin Arthritis Rheum. 2012. PMID: 22595642
-
Neuropsychiatric manifestations and their attribution to systemic lupus erythematosus: a retrospective single-center study in a Polish population.Pol Arch Intern Med. 2022 Nov 25;132(11):16319. doi: 10.20452/pamw.16319. Epub 2022 Aug 18. Pol Arch Intern Med. 2022. PMID: 35984958
-
A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.Autoimmun Rev. 2016 Feb;15(2):124-38. doi: 10.1016/j.autrev.2015.10.003. Epub 2015 Oct 23. Autoimmun Rev. 2016. PMID: 26497108 Review.
-
Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions.Front Immunol. 2022 Aug 9;13:957303. doi: 10.3389/fimmu.2022.957303. eCollection 2022. Front Immunol. 2022. PMID: 36016935 Free PMC article. Review.
Cited by
-
The conundrum of neuropsychiatric systemic lupus erythematosus: Current and novel approaches to diagnosis.Front Neurol. 2023 Mar 21;14:1111769. doi: 10.3389/fneur.2023.1111769. eCollection 2023. Front Neurol. 2023. PMID: 37025200 Free PMC article. Review.
-
Neuropsychiatric Systemic Lupus Erythematosus in Older Adults: Diagnosis and Management.Drugs Aging. 2022 Feb;39(2):129-142. doi: 10.1007/s40266-021-00911-0. Epub 2021 Dec 16. Drugs Aging. 2022. PMID: 34913146 Review.
-
Systemic Lupus Erythematosus Presenting as Walking Corpse Syndrome.Cureus. 2023 Jun 1;15(6):e39840. doi: 10.7759/cureus.39840. eCollection 2023 Jun. Cureus. 2023. PMID: 37397652 Free PMC article.
-
Seizures as a rare adverse effect of chloroquine therapy in systemic lupus erythematosus patients: a case report and literature survey.Postepy Dermatol Alergol. 2018 Aug;35(4):429-430. doi: 10.5114/ada.2018.77675. Epub 2018 Aug 21. Postepy Dermatol Alergol. 2018. PMID: 30206460 Free PMC article. No abstract available.
-
Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus.Front Med (Lausanne). 2018 Mar 14;5:68. doi: 10.3389/fmed.2018.00068. eCollection 2018. Front Med (Lausanne). 2018. PMID: 29594125 Free PMC article. Review.
References
-
- Kaposi MK. Neue Beitrage zur Kenntnis des Lupus erythematosus. Arch Dermatol Syph. 1982;4:36–78.
-
- Brey RL, Hollyday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology. 2002;58:1214–1220. - PubMed
-
- Bertsias GK, Ioannidis JPA, Boletis J, et al. EULAR recommendations for the management of Systemic Lupus Erytematosus (SLE). Report of a Task Force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). ARD online. 2007 available: http://journals.bmj.com/cgi/reprint form. - PubMed
-
- Jennekens FGI, Kater L. The central nervous system in systemic lupus erythematosus. Part I. Clinical syndromes: a literature investigation. Rheumatology. 2002;41:605–618. - PubMed
-
- Karassa FB, Afeltra A, Ambrozic A, et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum. 2006;54:312–324. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous